Sale

EQS-News: Ekosem-Agrar AG plans to restructure its outstanding corporate bonds

Retrieved on: 
Wednesday, April 10, 2024
EUR, SDK, Joint, ESA, Webcast, FAQ, Sale, Bank statement, Federal Gazette, Gesellschaft mit beschränkter Haftung, Security (finance)

The proposed measures essentially comprise the sale and transfer of the outstanding bonds including accrued interest at a purchase price of EUR 300.00 per bond with a nominal value of EUR 1,000.00.

Key Points: 
  • The proposed measures essentially comprise the sale and transfer of the outstanding bonds including accrued interest at a purchase price of EUR 300.00 per bond with a nominal value of EUR 1,000.00.
  • Furthermore, the management plans to merge the German holding company with the operating business, which is based exclusively in Russia.
  • The current shareholders of Ekosem-Agrar AG will essentially hold the shares in the acquiring company.
  • Our bonds have been an important financial pillar in building up our business since 2012, combined with an attractive return for our noteholders.

EQS-News: IKB Deutsche Industriebank AG figures for the 2023 financial year: Solid figures achieved in a difficult environment

Retrieved on: 
Wednesday, April 10, 2024
ESF, Tax, IKB, Pressure, Risk management, Growth, Environment, Risk, Pension, IKB Deutsche Industriebank, Bank, Sale, Acquisition, Common equity, Depreciation, Administration, NPL, EDB, KfW, Corporation

IKB Deutsche Industriebank AG figures for the 2023 financial year: Solid figures achieved in a difficult environment

Key Points: 
  • IKB Deutsche Industriebank AG figures for the 2023 financial year: Solid figures achieved in a difficult environment
    The issuer is solely responsible for the content of this announcement.
  • IKB Deutsche Industriebank AG figures for the 2023 financial year: Solid figures achieved in a difficult environment
    Ample liquidity with free available liquidity reserve of €1.4 billion (previous year: €1.2 billion)
    Dr Michael Wiedmann, Chairman of the Board of Managing Directors of IKB: “We have met our annual targets and are on track to achieving our medium-term goals.
  • 2023 was largely characterised by the increase in market interest rates against a difficult economic backdrop.
  • Table: IKB income statement for the 2023 financial year (Group, in accordance with German commercial law)

EQS-News: XTPL strengthens its presence in the USA

Retrieved on: 
Wednesday, April 10, 2024
Electronics, Sale, Business development, University, PLN, MBA, DPS, News, Delta, Urs, ICT

XTPL will deliver the Delta Printing System (DPS) device to a new client based in California in Q2 2024.

Key Points: 
  • XTPL will deliver the Delta Printing System (DPS) device to a new client based in California in Q2 2024.
  • The XTPL technology will be used in work on packaging for integrated microelectronic devices.
  • XTPL's broader activity in the USA is supported by Urs Berger, Managing Director for North America.
  • Before joining XTPL, he held key management roles at Optomec in the United States and Switzerland with a responsibility for Business Development.

EQS-News: Heidelberg Pharma announces financial figures and reports on successful business performance in 2023

Retrieved on: 
Wednesday, April 10, 2024
Malignancy, Spanish mythology, State university system, Patient, Sale, Renal cell carcinoma, Clinical trial, Neoplasm, Therapy, Depreciation, HPHA, USD, Marketing, GLP, Health, Research, ATACS, EPO, Immune system, ADC, BLA, ATAC, Food, Biologics license application, Disease, Magenta, Multiple myeloma, AACR, GCC, Annual report, FDA, Diagnosis, EUR, Supervisory board, Accounting, PET, EDT, Spacecraft, Amanitin, European Patent Convention, Patent, Eli Lilly and Company, Binghamton University, Pharmaceutical industry

Minority interest in Emergence sold: In summer 2023, Heidelberg Pharma sold its minority interest in Emergence Therapeutics AG, Duisburg, Germany, (Emergence).

Key Points: 
  • Minority interest in Emergence sold: In summer 2023, Heidelberg Pharma sold its minority interest in Emergence Therapeutics AG, Duisburg, Germany, (Emergence).
  • As a result, Heidelberg Pharma lost sales revenue in the low single-digit millions for the 2023 financial year.
  • In April 2023, Heidelberg Pharma signed a termination agreement with Magenta under which all licensed ATAC rights and some Magenta patents were assumed by Heidelberg Pharma.
  • The Heidelberg Pharma Group includes two entities, Heidelberg Pharma AG and Heidelberg Pharma Research GmbH.

EQS-News: Wacker Neuson Group: strong revenue and earnings growth in fiscal 2023 – focus on Strategy 2030

Retrieved on: 
Wednesday, April 10, 2024
Remuneration, Annual, EUR, Uncertainty, Tax, Growth, Supervisory board, Policy, Sale, Weidemann, Investment, Renewable energy

Earnings before interest and taxes (EBIT) increased even faster at 35.4 percent and reached EUR 273.2 million (2022: EUR 201.8 million).

Key Points: 
  • Earnings before interest and taxes (EBIT) increased even faster at 35.4 percent and reached EUR 273.2 million (2022: EUR 201.8 million).
  • “Fiscal 2023 began with dynamic growth, which increasingly gave way to downward trends across many sectors of the economy in the second half of the year.
  • Double-digit growth – breakdown of revenue by region: Revenue in Europe (EMEA) increased by 18.3 percent to EUR 2,022.4 million (2022: EUR 1,709.9 million).
  • At EUR 76.0 million, revenue in Asia-Pacific fell by 8.9 percent in fiscal 2023 (2022: EUR 83.4 million).

Yandex N.V. provides an update on the divestment of its Russia-based businesses

Retrieved on: 
Wednesday, April 10, 2024
Control, RUB, Federal Antimonopoly Service, Sale, Yandex, Foreign direct investment

The company has made significant progress towards the implementation of the proposed transaction.

Key Points: 
  • The company has made significant progress towards the implementation of the proposed transaction.
  • On March 7, we received the requisite Shareholder approvals (including the separate approval of Class A shareholders) for the divestment and related amendments to YNV’s articles of association.
  • All of Yandex's assets and operations in Russia and certain international markets, which form the divestment perimeter, are now held by IPJSC “Yandex”, an international public joint stock company incorporated in Russia.
  • IPJSC “Yandex” has recently obtained a public company status and applied for a primary listing on the Moscow Exchange.

Polymetal International plc: New management appointments in Kazakhstan

Retrieved on: 
Wednesday, April 10, 2024
JSC, Construction, Yuri, Mineral Resources Limited, International, Technical, Roman, Sale, University, Kazakhmys, Mineral processing, Legal Affairs, Polymetal, Institute of technology, Resource, Mining engineering, Polymetal International, Production, Management

Polymetal International plc (“Polymetal”, the “Group”) announces significant strengthening of the management team.

Key Points: 
  • Polymetal International plc (“Polymetal”, the “Group”) announces significant strengthening of the management team.
  • “The natural first step after the sale of the Russian business is the creation of strong, focused, and motivated management team in our corporate headquarters in Astana.
  • With the appointment of four new Executive Vice Presidents, Polymetal is now in a position to advance its independent strategy in Central Asia”, said Vitaly Nesis, Group CEO of Polymetal International plc.
  • Valery joined Polymetal Engineering in 2006 and moved to Kyzyl in 2016.

EQS-News: Instone Group achieves upper end of earnings guidance; outlook for 2024 assumes continued solid profitability in a year of transition

Retrieved on: 
Wednesday, April 10, 2024
EUR, Weakness, Environment, Real, Sale, GDV, EAT, Housing, LTC, Video game

Instone Group achieves upper end of earnings guidance; outlook for 2024 assumes continued solid profitability in a year of transition

Key Points: 
  • Instone Group achieves upper end of earnings guidance; outlook for 2024 assumes continued solid profitability in a year of transition
    The issuer is solely responsible for the content of this announcement.
  • The negative effects of higher interest rates and the increased uncertainty of private and institutional investors remained clearly noticeable in 2023.
  • However, there was an upturn in retail sales during the course of the year and particularly in the final quarter.
  • The Instone Group continues to benefit from the high share of projects that have already been sold.

EQS-News: EPH Group AG: New appointments to the Management Board and Supervisory Board

Retrieved on: 
Wednesday, April 10, 2024
Credit Suisse First Boston, VP Bank, ABN, Wiener Börse, Risk management, Supervisory board, ABN AMRO, Sale, IPO, Investment, Tourism, LGT, Kitzbühel Alps, EPH, Security (finance)

Vienna, April 3, 2024 - Alexander Lühr (50) becomes new member of the Management Board of EPH Group AG.

Key Points: 
  • Vienna, April 3, 2024 - Alexander Lühr (50) becomes new member of the Management Board of EPH Group AG.
  • The Supervisory Board of EPH Group AG has appointed Alexander Lühr as a new member of the Management Board with effect from today.
  • This change in the composition of the Supervisory Board was approved by yesterday's Annual General Meeting of the Vienna-based EPH Group AG.
  • At the following Supervisory Board meeting, Jürgen Geisler was elected Chairman of the Supervisory Board.

EQS-News: STRABAG SE: Implementation of non-cash capital increase entered in the commercial register; details on issuance of new shares and cash distribution

Retrieved on: 
Wednesday, April 10, 2024
Wiener Börse, Interest, Exercise, Construction, Communication, Environment, Climate, Sale, Person, AMERICA, Publication, Annual general meeting, Investment, STRABAG, Prospectus, KMG, UBO, Security (finance)

STRABAG SE: Implementation of non-cash capital increase entered in the commercial register; details on issuance of new shares and cash distribution

Key Points: 
  • STRABAG SE: Implementation of non-cash capital increase entered in the commercial register; details on issuance of new shares and cash distribution
    The issuer is solely responsible for the content of this announcement.
  • The implementation of the ordinary non-cash capital increase was registered in the commercial register by the Klagenfurt Regional Court as planned on 21/03/2024.
  • The 15,621,982 new shares from the capital increase will be issued on 26/03/2024 to the holders of existing STRABAG shares under ISIN AT0000A36HH9 (STRABAG SE – Distribution Share-Based Option).
  • The distribution of the securities for receipt of the cash distribution of the capital reduction amount (ISIN AT0000A36HK3) to the holders of existing STRABAG shares with ISIN AT000000STR1 will also occur on 26/03/2024.